Cox regression for in-hospital survival | Cox regression for 3-year follow-up survival | |||
---|---|---|---|---|
HR unadjusted | HR adjusted | HR unadjusted | HR adjusted | |
Group L, ScvO2 < 60 | 1.377 (0.905–2.096), | 2.124 (0.985–4.582), | 1.126 (0.911–1.392), | 1.209 (0.893–1.638), |
P = 0.135 | P = 0.055 | P = 0272 | P = 0.220 | |
Group H, ScvO2 > 80 | 1.709 (1.244–2.348), | 2.787 (1.565–4.964), | 1.462 (1.244–1.718), | 1.314 (1.033–1.672), |
P = 0.001 | P <0.001 | P <0.001 | P = 0.026 | |
Age in years | 1.039 (1.023–1.056), | 1.096 (1.056–1.138), | 1.050 (1.041–1.058), | 1.044 (1.029–1.059), |
P <0.001 | P <0.001 | P <0.001 | P <0.001 | |
Type of surgery: valves | 1.480 (1.083–2.022), | 1.858 (0.991–3.458), | 1.596 (1.369–1.860), | 1.438 (1.124–1.840), |
P = 0.014 | P = 0.054 | P <0.001 | P = 0.004 | |
Type of surgery: CABG + valves | 1.469 (0.978–2.207), | 1.747 (0.846–3.608), | 1.835 (1.519–2.218), | 1.281 (0.961–1.703), |
P = 0.064 | P = 0.132 | P <0.001 | P = 0.088 | |
Duration of surgery, minutes | 1.003 (1.002–1.004), | 1.002 (1.001–1.004), | ||
P <0.001 | P = 0.010 | |||
Pre–operative ACEF score | 2.609 (2.232–3.050), | 1.379 (1.124–1.693), | ||
P <0.001 | P = 0.002 | |||
APACHE II score on ICU admission | 1.049 (1.039–1.060), | 1.030 (1.014–1.047), | ||
P <0.001 | P <0.001 | |||
TISS score on ICU admission | 1.088 (1.069–1.107), | 1.100 (1.060–1.142), | 1.056 (1.045–1.068), | 1.028 (1.009–1.047), |
P <0.001 | P <0.001 | P <0.001 | P = 0.004 | |
Atrial fibrillation | 2.147 (1.869–2.466), | 1.674 (1.340–2.091), | ||
P <0.001 | P <0.001 | |||
COPD | 1.798 (1.538–2.102), | 1.497 (1.173–1.910), | ||
P <0.001 | P = 0.001 | |||
Diabetes mellitus | 1.440 (1.070–1.939), | 2.076 (1.173–3.675), | 1.735 (1.512–1.990), | 1.405 (1.137–1.736), |
P = 0.016 | P = 0.012 | P <0.001 | P = 0.002 | |
Peripheral vascular disease | 1.485 (1.100–2.006), | 1.835 (1.064–3.164), | 1.865 (1.601–2.174), | 1.733 (1.364–2.201), |
P = 0.010 | P = 0.029 | P <0.001 | P <0.001 | |
Dobutamine, cumulative dosage mg/24 hours | 0.999 (0.998–0.999), | 0.999 (0.999–1.000), | ||
P <0.001 | P = 0.098 | |||
Enoximone, cumulative dosage mg/24 hours | 1.000 (1.000–1.000), | 0.999 (0.998–1.000), | ||
P = 0.002 | P = 0.144 | |||
Norepinephrine, cumulative dosage mg/24 hours | 1.014 (1.012–1.017), | 1.018 (1.011–1.024), | 1.015 (1.012–1.017), | 1.016 (1.011–1.021), |
P <0.001 | P <0.001 | P <0.001 | P <0.001 |